TRPV4 and ovarian cancer: Furthermore, in patients with colon adenocarcinoma (COAD) or ovarian cancer, high TRPV4 expression was associated with worse overall survival (OS), disease-specific survival (DSS), disease-free interval (DFI), and progression-free interval (PFI).